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Type 1 autoimmune pancreatitis (AIP) is a prototype of IgG4-related disease (IgG4-RD) and 
IgG4-related sclerosing cholangitis (IgG4-SC) is the biliary manifestation of IgG4-RD. Recently, 
IgG4-RD is well-recognized as a systemic disease affecting most organs and the diagnosis criteria in 
each organ has been established or is currently being researched. Both extrahepatic bile ducts and 
pancreatic ducts of the ventral pancreas embryologically originate from the common duct in the 4th 
fetal week. In addition to the similarities in their histogenesis and histology, similarities in AIP and 
IgG4-SC are also recognized such as prominent IgG4-positive cells, storiform-type fibrosis, and 
obliterative phlebitis in their affected portions. Although the diagnosis of IgG4-RD is relatively easy 
in surgical specimens, the tiny mucosal surface specimens obtained by biopsy procedure do not 
contain enough material to reach a definitive diagnosis. Moreover, the presence of IgG4-positive 
cells in tissue and increased serum IgG4 levels are often found in patients with biliary and pancreatic 
cancers. The diagnosis of IgG4-RD in the pancreatiobiliary system, especially in biopsy specimens, 
is clinicopathologically necessary to consider every possibility. 
 
INTRODUCTION 
Although patients with IgG4-related disease (IgG4-RD) or its similar diseases, including 
autoimmune pancreatitis (AIP), have been retrospectively reported as other disease names in several 
organs, such as Mikulicz disease and Sjögren's syndrome with IgG4 hypergammaglobulinemia, the 
characteristic of increased serum IgG4 levels as a unique clinicopathological entity in one type of 
AIP (type 1 AIP) has been reported by Hamano et al from Shinshu University in 2001 (1). IgG4 is 
the most minor immunoglobulin subtype of IgG (3–6% of all circulating IgG in adults) and lack a 
complement activity (1). The physiological and pathological significance of IgG4 remains unknown 
in both healthy and diseased individuals including IgG4-RD. Since the presence and 
etiopathogenesis of IgG4-RD have attracted widespread attention, almost all organs have been 
revealed to be affected in IgG4-RD (2). Type 1 AIP is the prototype of IgG4-RD and IgG4-related 
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sclerosing cholangitis (IgG4-SC) is a biliary manifestation of IgG4-RD. In this chapter, the 




 In present medical practice, IgG4-RD is always raised as a differential diagnosis in the 
diagnosis of tumorous or stenotic lesions in most organs (2, 3). Differing from the pancreatiobiliary 
system, gastrointestinal tracts are not typically affected in IgG4-RD and manifestation in this area is 
limited to several case reports (4). Regardless of the organ involved in IgG4-RD, elevated serum 
IgG4 values, marked IgG4-positive plasmacytic cell infiltration in affected organs, and marked 
efficacy of steroid therapy are common characteristics, in addition to organ-specific histological 
findings (1, 5, 6). A comprehensive diagnostic criterion (2) has been proposed, which can be applied 
to any affected organs, and organ-specific criteria systems have also been proposed in some organs 
including the pancreas and biliary tracts (7, 8). Comprehensive criteria (2) consist of increased IgG4 
serum levels (>135 mg/dl) and prominent IgG4-positive cells (>40% of IgG-positive plasma cells 
being IgG4-positive and >10 cells/hpf) in biopsy specimens. In addition to these common features, 
as mentioned below, IgG4-related AIP (type 1 AIP) and IgG4-SC are histologically characterized by 
the unique pathologies of uncontrolled progressive fibrosis, inducing sclerosis, and storiform-pattern 
fibrosis, but several organs such as lymph nodes lack such fibrosis in IgG4-RD. Although the 
etiopathogenesis of IgG4-RD is still unknown, allergic or autoimmune mechanisms against extrinsic 
or intrinsic (auto-) antigens are speculated, because of the increased number of eosinophils, the 
presence of autoantibodies, and the effectiveness of immunosuppressive treatments (9, 10). 
 
Type 1 AIP 
 The term AIP was first proposed by Yoshida et al. in 1995 (11). At present, broad AIP 
consists of two different etiopathogenesis, type 1 and type 2. Type 1 AIP is the prototype of 
IgG4-RD and originally reported as a lymphoplasmacytic sclerosing pancreatitis (LPSP) from the 
pathological concept in 1991 (12). In contrast, type 2 AIP is not associated with IgG4 and is 
characterized by the infiltration of neutrophils in epithelial layers of pancreatic ducts. Type 2 AIP is 
also known as idiopathic duct-centric chronic pancreatitis (IDCP) (13) or autoimmune pancreatitis 
with granulocytic epithelial lesion (GEL) (14). Among cases AIP in Japan, type 1 is common and 
type 2 is very rare.  
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In addition to clinical behaviors, such as increased IgG4 levels and a good response to 
steroid treatments, the histopathology of type 1 AIP is characterized by the presence of marked 
lymphoplasmacytic infiltration including IgG4-positive cells (mostly IgG4-positive plasmablasts), 
and fibrosis (Fig. 1A, D). In addition to these chronic inflammatory cells, several eosinophils and 
lymph follicle formations are also occasionally found. Lining epithelial cells are well-preserved (Fig. 
1A) and erosive change with neutrophil infiltration is scarce. These inflammatory findings are 
predominantly found around pancreatic ducts. Pancreatic duct glands have recently been identified 
as a distinct ductal component of the pancreas and are located within the pancreatic duct wall (15, 
16). There are no reports indicating that pancreatic duct glands are preferably affected in type 1 AIP, 
but pancreatic duct glands as well as pancreatic exocrine acinus is concurrently involved in 
inflammation. Although disease progression destroys the pancreatic exocrine acinus, the lobular 
architecture is relatively preserved (Fig. 1E). In particular, the fibrosis pattern in type 1 AIP is a 
characteristic sclerosing type called as a storiform or swirling fibrosis, which shows irregularly 
whorled patterns (Fig. 1E). Moreover, the intermingled fibrosis of many collagen and inflammatory 
cells are pathognomonic for this type fibrosis, differing from general scar-like secondary fibrosis. 
These fibrous and inflammatory changes cause thickening of the wall of the pancreatic duct and 
expanded into the acinus and also peripancreatic adipose tissue with the development of the disease 
state (Fig. 1E).  
In peripheral pancreatic parenchyma and peripancreatic fatty areas, in addition to the 
storiform fibrosis, other pathognomonic findings, such as obliterative phlebitis in small venules and 
the concentration of IgG4-positive cells around nerve bundles, are often found (Fig. 1B, F). 
Therefore, the border between pancreatic parenchyma and peripancreatic fatty tissue is unclear in the 
development of interface inflammation and fibrosis (Fig. 1E). Because the comprehensive diagnostic 
criterion mentioned above is not sufficiently sensitive for the diagnosis of type 1 AIP, 
pancreas-specific diagnostic criteria have increased the sensitivity of diagnosis for type 1 AIP (8, 17). 
A marked IgG4-positive cell infiltration does not constitute adequate pathological evidence for the 
diagnosis of IgG4-RD. Care must be taken not to be overly influenced by diagnostic criteria that 




IgG4-SC is a biliary manifestation of systemic IgG4-RD, which is diffusely or focally 
affected in the extrahepatic biliary tree consisting of the large bile ducts of hepatic hilus, common 
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bile ducts, and the gallbladder. IgG4-SC is preferably found in older males (male:female = 4:1; 
mean: 67 years; mostly 50 years or older) (18, 19). IgG4-SC is diagnosed in 13%–19.5% of patients 
with IgG4-RD. Serum IgG4 levels are elevated in 89.5% patients with IgG4-SC without AIP (9, 19, 
20), indicating that only lesion of IgG4-SC could reflect the increased serum IgG4. IgG4-SC is 
accompanied by type 1 AIP in approximately 90% of patients (19, 21). On the other hand, 
approximately 80% of AIP patients have complications with the stenosis of the intrapancreatic bile 
duct (distal common bile duct) (22), but it is controversial whether this involvement of the 
intrapancreatic bile duct in AIP patients is associated specifically with IgG4-SC or not. 
Histopathologically, the morphology of IgG4-SC greatly resembles that of AIP and both share the 
same pathological characteristics as IgG4-RD. Primary sclerosing cholangitis (PSC) and 
cholangiocarcinoma are clinicopathologically important and require differentiation from IgG4-SC, 
because each of them requires an exact diagnosis for appropriate treatments. IgG4-SC complicating 
type 1 AIP can be differentiated using the same diagnostic criteria used for AIP (8). However, 
IgG4-SC without any lesions in the other affected organs, including the pancreas, is often hard to 
diagnose prior to commencement of treatment, and its differentiation from disease conditions 
including PSC and cholangiocarcinoma is especially important. Differing from PSC pathologically, 
the inflammation in IgG4-SC is prominently found in the peribiliary glands existing in the middle 
layer of the bile duct wall, rather than in the mucosal layer of the bile ducts (Fig. 1B, C). Therefore, 
biliary epithelial cells lining the bile ducts are usually well-preserved, and erosive change and 
neutrophil infiltration are scarce in the affected bile ducts (Fig. 1B). However, IgG4-SC cases with 
atypical features, such as those lacking increased serum IgG4 levels or with premalignant lesions, 
have been reported (23-25). Moreover, IgG4 reaction is often seen in several cancers including 
cholangiocarcinoma and pancreatic cancers (26, 27). Therefore, IgG4-positive cell infiltration is not 
a specific pathological finding in IgG4-RD. When making a pathological diagnosis, specific 
attention must be paid to this point. Recently, in clarifying the clinicopathological features and the 
pathogenesis of IgG4-RD and similar diseases, the diagnostic criteria of IgG4-SC has gradually 
being distinguished. At present, a diagnostic criteria for IgG4-SC has been proposed in Japan (7). 
Characteristic and diagnostically-useful histological findings of bile duct specimens include: 1. 
IgG4-positive plasmacytic cell infiltration （≥10/hpf and IgG4/IgG positive cell ratio ≥40%）, 2. 
marked lymphoplasmacytic cell infiltration and fibrosis without neutrophil infiltration, 3.  
obliterative phlebitis or swirling fibrosis, and 4. storiform fibrosis. However, it is generally difficult 
to identify such histological features in small biopsy specimens obtained from the surface of bile 
5 
ducts. Each individual case should be diagnosed clinicopathologically based on its own individual 
features. 
 
Similarity of pancreatiobiliary lesions in IgG4-RD 
Embryologically, biliary tracts and the pancreas develop from the endoderm foregut from the 
4th fetal week. In adults, extrahepatic bile ducts and pancreatic ducts are morph-phenotypically 
similar; that is, both are covered by a single layer of columnar cells with mucus production and the 
same keratin patterns, and both are accompanied by periductal glands such as peribiliary glands and 
pancreatic duct glands (15, 16). In addition to these embryological and histological similarities, 
some pancreatic and biliary diseases also share unique pathological features. For example, 
extrahepatic cholangiocarcinoma, pancreatic ductal adenocarcinoma, papillary neoplasia (intraductal 
papillary-mucinous neoplasm [IPMN] of pancreatic duct and intraductal papillary neoplasm of the 
bile duct [IPNB]), precancerous lesions (biliary intraepithelial neoplasia [BilIN], and pancreatic 
intraepithelial neoplasia [PanIN]) share many clinicopathological features (28). In addition to the 
associations with their carcinomas and carcinogenesis, the histopathology of bile duct lesions in 
IgG4-SC in some respects resembles those of the pancreatic duct in type 1 AIP and the same patients 
synchronously or asynchronously are affected with them. In addition to the common histological 
features in type 1 AIP and IgG4-SC, the following have also been suggested; 1. inflammation mostly 
affects the wall of the biliary and pancreatic ducts involving peribiliary glands and pancreatic duct 
glands; 2. lining epithelium in both ducts is relatively well-preserved, though their mucosa surfaces 
are inflamed accompanying IgG4-positive cells; 3. chronic sclerosing inflammation consisting of 
marked lymphoplasmacytic cells and fibrosis and inducing luminal stenosis; 4. storiform pattern 
fibrosis; 5. these inflammation and fibrosis extend into the adipose tissue around the pancreas and 
hepatic hilus; 6. immunohistochemistry highlights numerous IgG4-positive plasmablastic cells; 7.  
obliterative phlebitis and perineural infiltration of IgG4-positive cells in tissues; 8. tumor-like lesions, 
also referred to as mass-forming pancreatitis and inflammatory pseudotumor, are sometime 
complicated (Fig. 1H). Moreover, similar mechanisms are clarified. Th2 cells producing Th2 
cytokines, such as IL4 and Foxp3+ regulatory T cells (Treg cells) producing interleukin 10 (IL10), 
are associated with the pathogenesis of AIP and also IgG4-SC (29). In particular, IL10 is a 
regulatory cytokine mainly produced by Treg cells, and Th2 cells induce the differentiation of 
IgG4-positive plasma cells or favor B cell switching to IgG4 in the presence of IL-4 (30, 31). 
Therefore, IgG4-SC and AIP form a disease spectrum in the pancreatico-biliary system against a 
background of the common pathophysiological features in bile ducts and the pancreas (28). 
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This concept could be applied in extrahepatic bile ducts, but not intrahepatic bile ducts. 
Intrahepatic and extrahepatic bile ducts share the same keratin patterns and drainage functions of 
bile, but differ from the histogenesis, mucus production, and accompanying periductal glands. As 
mentioned above, extrahepatic bile ducts, including the large bile duct in hepatic hilus and the 
gallbladder, and pancreatic ducts are developed from the foregut in the same fetal week. Intrahepatic 
bile ducts in the peripheral liver are derived from the ductal plate, which is thought to contain 
hepatic progenitor cells, and embryologically differ from extrahepatic bile ducts. The anatomical 
distribution of IgG4-SC is limited in extrahepatic bile ducts, reflecting the similarity in the 
pathogenesis of type 1 AIP. In fact, IgG4-positive cells are found in the peripheral small portal tracts, 
which are contained in the liver biopsies taken from patients with IgG4-RD (32). However, the 
presence of IgG4-posiive cells in small portal tracts is not the lesion affecting peripheral small bile 
ducts, which is speculated to be just the extended inflammation along the intrahepatic biliary tree 
from extrahepatic bile ducts in IgG4-SC. It is unknown why intrahepatic bile ducts are not directly 
affected in IgG4-RD as they are in IgG4-SC, but it suggests that the diseases and pathogenesis found 
in extrahepatic bile ducts is similar to those in pancreatic ducts, and that intrahepatic bile ducts do 
not apply to the “biliary diseases with pancreatic counterparts” (28).  
   
IgG4 reaction in pancreatiobiliary carcinoma 
Elevated serum IgG4 levels are not always helpful for achieving a differential diagnosis 
(1, 33). The elevation of serum IgG4 levels is important in the diagnosis of IgG4-RD, but is not 
necessarily specific to IgG4-RD, because this increase is found in patients with PSC, 
cholangiocarcinoma, pancatic cancers, and several inflammatory diseases of other organs, such as 
atopic dermatitis, pemphigus, asthma, and even a non-selected cohort of patients (approximately 
7%), and approximately 10% patients of IgG-SC or AIP lack increased serum IgG4 levels (9, 22, 26, 
34). Moreover, several cases of pancreatic cancer and cholangiocarcinoma are accompanied by IgG4 
reaction and/or elevated serum IgG4 levels (27, 33, 35, 36) and also a few cases of pancreatic cancer 
or cholangiocarcinoma arising from IgG4-SC or type 1 AIP, respectively, have been reported (37, 
38), suggesting an association between cancer-related immunity and IgG4 reaction. As mentioned 
above, Treg cells and regulatory cytokine IL10 are associated with the pathogenesis of AIP and 
IgG4-SC (29). Treg cells and IL10 are also involved in carcinogenesis of pancreatic duct carcinoma 
and cholangiocarcinoma, because this regulatory cytokine network reflects evasion from immune 
surveillance in carcinogenesis (26). An IgG4 reaction consisting of abundant IgG4-positive cells in 
tissue may simply be the result of an immunoreaction within a Th2 and regulatory cytokine milieu 
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(26, 29, 30). Therefore, an IgG4 reaction is speculated to nonspecifically occur in several 
inflammatory and cancerous lesions, and the presence of IgG4-positive cells is not a histological 
hallmark of IgG4-RD. To diagnose IgG4-SC and AIP, particularly to deny the malignancy in 
stenotic portions, biopsy and cytological examination are necessary to exclude malignancies and 
establish a diagnosis. Therefore, differentiating IgG4-SC or AIP cases without other organ 
involvement of IgG4-RD from PSC, cholangiocarcinoma, and pancreatic cancers is challenging 
(39-41). Moreover, carcinogenesis in IgG4-RD has been noted (42), and there have also been a few 
reported cases of IgG4-SC accompanied by cholangiocarcinoma or BilIN lesions (23, 37, 38, 43-46). 
Our previous survey demonstrated that the IgG4 reaction in biliary tract cancers occurs at various 
degrees in most cholangiocarcinoma cases located in the extrahepatic biliary tree (Fig. 2), but very 
rarely in cholangiocarcinoma of the liver (intrahepatic cholangiocarcinoma). It is unknown why 
intrahepatic cholangiocarcinoma accompanies scarce IgG4 reaction, but one interesting possibility is 
raised that this IgG4 reaction is limited by the embryological and anatomical similarities between 
extrahepatic bile ducts and pancreatic ducts (26, 28, 34, 47). 
 
Concluding remarks 
Increased IgG4 levels in serum and organs are unique and valuable features of IgG4-RD. 
Extrahepatic bile duct and the pancreas are also involved in this disease and their manifestations are 
recognized from the concept of this book, "Biliary diseases with pancreatic counterparts". The 
pathological significance of IgG4 reaction found in other contexts as well as IgG4-RD need to be 
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Fig. 1   Representative histological features in AIP and IgG4-SC. A: Pancreatic duct. Inflammation 
and sclerosing fibrosis are found in the periductal area in AIP. B: Lower common bile duct 
(intrapancreastic bile duct). Inflammation extends from the ductal wall into the periductal area, in 
which perineural inflammation is found (arrowhead). Lining epithelia is preserved (arrows). C: 
Upper common bile duct. Inflammation concentrated around the peribiliary glands (arrows). D: 
Inflammation consists of plasmablasts, plasma cells, and lymphocytes. E: Interface area of the 
pancreas (left below) and peripancreatic fatty tissue (upper right). Storiform pattern-severe 
sclerosing fibrosis (*) is found intermingling with inflammation. Acinus is destroyed and slightly 
atrophic with fibrosis, but lobular architecture is remaining (left below). F: Elastica van Gieson 
staining highlights obliterative phlebitis (arrow). G: IgG4 immunohistochemistry reveals abundant 
positive plasma cells or plasmablasts. H: Type 1 AIP forming a mass-like nodular formation 
(mass-forming pancreatitis).  
 
Fig. 2   Cholangiocarcinoma with abundant IgG4-positive cells (common bile duct cancer). A: 
Ordinary adenocarcinoma is found with marked inflammation. B: IgG4 immunohistochemistry 
highlights abundant positive cells within the carcinoma. Scale is 5 mm. 
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